BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Reuters01-30

BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio <a href="https://laohu8.com/S/MSTR">Strategy</a>

Jan 29 (Reuters) - Nuwellis Inc NUWE.O:

NUWELLIS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE RENDIATECH, ADVANCING ITS CARDIORENAL PORTFOLIO STRATEGY

Source text: ID:nGNXYV7fP

Further company coverage: NUWE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2607157051?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 05:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607157051","market":"nz","top_or_hot":-1,"title":"BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio <a href=\"https://laohu8.com/S/MSTR\">Strategy</a></title></head><body><p><span>Jan 29 (Reuters)</span><span> - </span>Nuwellis Inc <span>NUWE.O</span>:</p><ul><li><p>NUWELLIS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE RENDIATECH, ADVANCING ITS CARDIORENAL PORTFOLIO STRATEGY</p></li></ul><p>Source text: <span>ID:nGNXYV7fP</span></p><p>Further company coverage: <span>NUWE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-30 05:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio <a href=\"https://laohu8.com/S/MSTR\">Strategy</a></title></head><body><p><span>Jan 29 (Reuters)</span><span> - </span>Nuwellis Inc <span>NUWE.O</span>:</p><ul><li><p>NUWELLIS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE RENDIATECH, ADVANCING ITS CARDIORENAL PORTFOLIO STRATEGY</p></li></ul><p>Source text: <span>ID:nGNXYV7fP</span></p><p>Further company coverage: <span>NUWE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUA4TF4FN:1","article_id":"2607157051","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607157051","pubTimestamp":1769722562,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio StrategyJan 29 (Reuters) - Nuwellis Inc NUWE.O:NUWELLIS ENTERS INTO DEFINITIVE AGREEMENT TO A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","NUWE":"Nuwellis, Inc."},"translate_title":"简介-Nuwellis签订收购Rendiatech的最终协议，推进其心肾投资组合战略","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUWE":0.9},"content_text":"BRIEF-Nuwellis Enters Into Definitive Agreement To Acquire Rendiatech, Advancing Its Cardiorenal Portfolio StrategyJan 29 (Reuters) - Nuwellis Inc NUWE.O:NUWELLIS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE RENDIATECH, ADVANCING ITS CARDIORENAL PORTFOLIO STRATEGYSource text: ID:nGNXYV7fPFurther company coverage: NUWE.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2607157051","isCrawlerRequest":true}